Early ImmuneRelated Adverse Events and Association with Outcome

  • Slides: 11
Download presentation
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non –Small Cell Lung

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non –Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study Shunsuke Teraoka, MD, Daichi Fujimoto, MD, Takeshi Morimoto, MD, MPH, Hayato Kawachi, MD, Munehiro Ito, MD, Yuki Sato, MD, Kazuma Nagata, MD, Atsushi Nakagawa, MD, Kojiro Otsuka, MD, Ph. D, Keiichiro Uehara, MD, Yukihiro Imai, MD, Ph. D, Kaori Ishida, MD, Ph. D, Junya Fukuoka, MD, Ph. D, Keisuke Tomii, MD, Ph. D Journal of Thoracic Oncology Volume 12 Issue 12 Pages 1798 -1805 (December 2017) DOI: 10. 1016/j. jtho. 2017. 08. 022 Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017.

Figure 1 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017.

Figure 2 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017.

Figure 3 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 1 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 1 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 2 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 2 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 3 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 3 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 4 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 4 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 5 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 5 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 6 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 6 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Supplementary Figure S 7 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j.

Supplementary Figure S 7 Journal of Thoracic Oncology 2017 121798 -1805 DOI: (10. 1016/j. jtho. 2017. 08. 022) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Association Between ImmuneRelated Adverse Events and Clinical OutcomesAssociation Between ImmuneRelated Adverse Events and Clinical Outcomes
Recognition and Management of ImmuneRelated Adverse Events irRecognition and Management of ImmuneRelated Adverse Events ir
Endocrine ImmuneRelated Adverse Events Jaydira Del Rivero MDEndocrine ImmuneRelated Adverse Events Jaydira Del Rivero MD
Adverse Events and Serious Adverse Events Jodie RileyAdverse Events and Serious Adverse Events Jodie Riley
Adverse Events Following Immunization AEFI Adverse Events FollowingAdverse Events Following Immunization AEFI Adverse Events Following
Adverse Selection What Is Adverse Selection Adverse selectionAdverse Selection What Is Adverse Selection Adverse selection
Educational Spotlight Adverse Event Reporting Adverse Events keyEducational Spotlight Adverse Event Reporting Adverse Events key
Outcome Page Outcome Page Outcome Page Progress NotesOutcome Page Outcome Page Outcome Page Progress Notes
Outcome Satisfied Outcome Not Satisfied Outcome Inconclusive TheOutcome Satisfied Outcome Not Satisfied Outcome Inconclusive The
Outcome Page Outcome Page Outcome Page Progress NotesOutcome Page Outcome Page Outcome Page Progress Notes